Pharmaceuticals, Biotechnology & Life Sciences Logo

Working At Aeglea Biotherapeutics

Zippia Score 4.2

Aeglea Biotherapeutics overview

Aeglea BioTherapeutics produces engineered human enzymes for cancer and rare genetic diseases. Click to find out more about our enzyme therapy research.
The average employee at Aeglea Biotherapeutics makes $102,962 per year, which is competitive for its industry and location. Some of its highest paying competitors, XBiotech, Corvus Pharmaceuticals, and SALADAX BIOMEDICAL, pay $103,281, $88,095, and $87,812, respectively.
Based in Austin, Texas, Aeglea Biotherapeutics is a small technology company with only 38 employees and an annual revenue of $4.9M.

The Organization’s Mission

Developing treatments for patients with rare genetic diseases and cancer.

Industry

Biotechnology

Revenue

$4.9M

Employees

38

Founded in

2013

Headquarters

Austin, TX

Website

aegleabio.com

Website

aegleabio.com

Organization Type

Private

Is This Your Company?

The team at Aeglea Biotherapeutics

Key People
  • Charles York (Executive Officer)
  • David Lowe (Executive Officer, Director)
  • Henry Skinner (Director)
  • Armen Shanafelt (Director)
  • George Georgiou (Director)

What do people say about Aeglea Biotherapeutics

Do you work at Aeglea Biotherapeutics ? Anonymously review Aeglea Biotherapeutics as an Employer.

What Do You Like About Working For Aeglea Biotherapeutics?

Aeglea Biotherapeutics Rankings

Aeglea Biotherapeutics is ranked #11 on the Best Technology Companies to Work For in Texas list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Aeglea Biotherapeutics Salaries

How much does Aeglea Biotherapeutics pay?
The national average salary for an Aeglea Biotherapeutics employee in the United States is $102,962 per year. Employees in the top 10 percent can make over $148,000 per year, while employees at the bottom 10 percent earn less than $71,000 per year.
9.9
Salary Score

Aeglea Biotherapeutics Salaries By Job Title

While Aeglea Biotherapeutics employees earn an average yearly salary of $102,962, different roles can command different wages. The higher paying positions at Aeglea Biotherapeutics include Senior Architect, Operations Manager, Information Technology Project Manager, and Software Engineer. A typical Senior Architect salary at Aeglea Biotherapeutics is $139,121 per year. Other roles at Aeglea Biotherapeutics include Maintenance Supervisor and Vehicle Mechanic. A Maintenance Supervisor at Aeglea Biotherapeutics earns an average yearly salary of $52,097.
00

Do you Work At Aeglea Biotherapeutics?

Help us make this company more transparent.

Aeglea Biotherapeutics Financial Performance

7.7
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

< $5M

Founded in

2013

Organization type

Private

Aeglea Biotherapeutics Financing Rounds

DateAmount
Mar 24, 2015Equity
$44,000,000

How Would You Rate The Company Culture Of Aeglea Biotherapeutics?

Have you worked at Aeglea Biotherapeutics? Help other job seekers by rating Aeglea Biotherapeutics.

Aeglea Biotherapeutics Competitors

Based on our research, similar companies to Aeglea Biotherapeutics are XBiotech, Corvus Pharmaceuticals, and SALADAX BIOMEDICAL. Employees at XBiotech earn more than most of the competition, with an average yearly salary of $103,281. The salaries at Corvus Pharmaceuticals average $88,095 per year, and the salaries at SALADAX BIOMEDICAL come in at $87,812 per year.
Company
XBiotechBiotechnology

Avg: $103,281

Corvus PharmaceuticalsBiotechnology

Avg: $88,095

SALADAX BIOMEDICALLife Sciences Tools and Services

Avg: $87,812

PROMEDIORBiotechnology

Avg: $84,998

TETRALOGIC PHARMBiotechnology

Avg: $84,643

Frequently Asked Questions about Aeglea Biotherapeutics

When was Aeglea Biotherapeutics founded?

Aeglea Biotherapeutics was founded in 2013.

How many Employees does Aeglea Biotherapeutics have?

Aeglea Biotherapeutics has 38 employees.

How much money does Aeglea Biotherapeutics make?

Aeglea Biotherapeutics generates $4.9M in revenue.

What industry is Aeglea Biotherapeutics in?

Aeglea Biotherapeutics is in the biotechnology industry.

What is Aeglea Biotherapeutics's mission?

Aeglea Biotherapeutics's mission statement is "Developing treatments for patients with rare genetic diseases and cancer."

What type of company is Aeglea Biotherapeutics?

Aeglea Biotherapeutics is a private company.

Who are Aeglea Biotherapeutics's competitors?

Aeglea Biotherapeutics competitors include XBiotech, KEREOS, Capstone Therapeutics, Greffex, PROMEDIOR, TETRALOGIC PHARM, Rosetta Genomics, SALADAX BIOMEDICAL, Cold Genesys, Humacyte, Inc., ViaCyte Inc., Boston Biomedical Inc., Aurora SFC Systems, Audentes Therapeutics, AveXis, AzurRx BioPharma, BioPharmX, Corvus Pharmaceuticals, CytomX Therapeutics, Edge Therapeutics Inc..

Who works at Aeglea Biotherapeutics?

Charles York (Executive Officer)

David Lowe (Executive Officer, Director)

Henry Skinner (Director)

Show More

Are you an executive, HR leader, or brand manager at Aeglea Biotherapeutics?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Aeglea Biotherapeutics, also known as AEGLEA BIOTHERAPEUTICS INC, Aeglea BioTherapeutics, Aeglea BioTherapeutics, Inc., Aeglea Biotherapeutics and Aeglea Biotherapeutics Inc.

Zippia gives an in-depth look into the details of Aeglea Biotherapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aeglea Biotherapeutics. The employee data is based on information from people who have self-reported their past or current employments at Aeglea Biotherapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Aeglea Biotherapeutics and its employees or that of Zippia.